Editas Medicine (EDIT) Cash & Equivalents (2014 - 2026)
Editas Medicine (EDIT) posted Cash & Equivalents of $146.65 million for Q4 2025, up 11.5% from $131.54 million a year earlier but down 11.5% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Cash & Equivalents (2014 - 2026) Analysis & Trends
Since Q1 2015, Editas Medicine has reported Cash & Equivalents for 44 quarters.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 1.0% (FY2020 to FY2025).
- In prior years, Editas Medicine's Cash & Equivalents was $131.54 million in FY2024 (+6.4%), $123.65 million in FY2023 (-12.6%), $141.52 million in FY2022 (-30.5%) and $203.52 million in FY2021 (+45.7%).
- Quarterly Cash & Equivalents has run from a low of $64.44 million in Q2 2024 to a high of $354.92 million in Q1 2021 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last six quarters, with growth averaging 25.6% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2025, with growth of 115.0%; the weakest was Q2 2024, with a decline of 70.8%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $165.65 million (Q3 2025), $138.54 million (Q2 2025) and $138.69 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Editas Medicine | 385.55 Mn | -286.59 Mn | 8.20 Mn | 93.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 93.17 Mn |
| Jun 30, 2026 | 181.82 Mn |
| Mar 31, 2026 | 123.65 Mn |
| Dec 31, 2025 | 146.65 Mn |
| Sep 30, 2025 | 165.65 Mn |
| Jun 30, 2025 | 138.54 Mn |
| Mar 31, 2025 | 138.69 Mn |
| Dec 31, 2024 | 131.54 Mn |
| Sep 30, 2024 | 95.83 Mn |
| Jun 30, 2024 | 64.44 Mn |
| Mar 31, 2024 | 69.23 Mn |
| Dec 31, 2023 | 123.65 Mn |
| Sep 30, 2023 | 82.54 Mn |
| Jun 30, 2023 | 220.82 Mn |
| Mar 31, 2023 | 129.02 Mn |
| Dec 31, 2022 | 141.52 Mn |
| Sep 30, 2022 | 210.70 Mn |
| Jun 30, 2022 | 169.40 Mn |
| Mar 31, 2022 | 210.88 Mn |
| Dec 31, 2021 | 203.52 Mn |
API Access
Editas Medicine Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();